Clinical Trials Directory

Trials / Completed

CompletedNCT01374763

A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Kati Järvelä · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to describe the effects of oxycodone/naloxone combination in comparison to oxycodone for the treatment of postoperative pain in patients undergoing cardiac surgery. The hypothesis is that the duration of opioid-induced bowel dysfunction and the need of laxatives will decrease.

Detailed description

Opioid-induced bowel dysfunction is common in cardiac surgery patients postoperatively. Opioids are needed to treat severe postoperative pain, but they have troublesome side-effects such as nausea, vomiting and bowel dysfunction. These symptoms also limit the use of gastrointestinal tract for nutrition and medication. Combined prolonged-releases oxycodone and naloxone has been shown to provide as effective analgesia as PR oxycodone. Oxycodone/naloxone has also been suggested to improve bowel function without compromising analgesic efficacy. The aim of the study is to describe the effects of oxycodone/naloxone combination in comparison to oxycodone for the treatment of postoperative pain in patients undergoing cardiac surgery. During the first three months of the study, all cardiac surgery patients will be treated with PR oxycodone. During the second part of the study (3 months), all cardiac surgery patients will be treated with PR oxycodone/naloxone. The primary end point is the duration of opioid-induced bowel dysfunction. Need of laxatives will be recorded.

Conditions

Interventions

TypeNameDescription
DRUGOxycodoneProlonged-release oxycodone 10-30 mg twice daily
DRUGProlonged-release oxycodone/naloxoneProlonged-release oxycodone/naloxone 10-30 mg twice daily

Timeline

Start date
2011-07-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-06-16
Last updated
2012-02-20

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01374763. Inclusion in this directory is not an endorsement.